Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (471-480 of 529) with videos related to

Pageof 53
Sort By:
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
The Journal of Infectious Diseases|January 10, 2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Kelly Seaton, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Scientific Reports|March 11, 2021
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacitiesMaria G Noval, Maria E Kaczmarek, Akiko Koide, et al.
Nature|May 29, 1997
The nucleotide sequence of Saccharomyces cerevisiae chromosome VF S Dietrich, J Mulligan, K Hennessy, et al.
Malaria Journal|June 6, 2015
Malaria elimination in Haiti by the year 2020: an achievable goal?Paul Jacques Boncy, Paul Adrien, Jean Frantz Lemoine, et al.
Plos One|September 6, 2007
Beringian standstill and spread of Native American foundersErika Tamm, Toomas Kivisild, Maere Reidla, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Pageof 53

Showing results (471-480 of 529) with videos related to

Sort By:
Pageof 53
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.
Annals of Neurology|March 15, 2022
Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational StudyIlya Kister, Yury Patskovsky, Ryan Curtin, et al.
The Journal of Infectious Diseases|January 10, 2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Kelly Seaton, et al.
The Journal of Infectious Diseases|February 9, 2022
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model InoculumNadine Rouphael, Allison Beck, Amy E Kirby, et al.
Scientific Reports|March 11, 2021
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacitiesMaria G Noval, Maria E Kaczmarek, Akiko Koide, et al.
Nature|May 29, 1997
The nucleotide sequence of Saccharomyces cerevisiae chromosome VF S Dietrich, J Mulligan, K Hennessy, et al.
Malaria Journal|June 6, 2015
Malaria elimination in Haiti by the year 2020: an achievable goal?Paul Jacques Boncy, Paul Adrien, Jean Frantz Lemoine, et al.
Plos One|September 6, 2007
Beringian standstill and spread of Native American foundersErika Tamm, Toomas Kivisild, Maere Reidla, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Pageof 53